Free Trial

Day One Biopharmaceuticals (DAWN) Insider Trading & Ownership

Day One Biopharmaceuticals logo
$6.28 +0.02 (+0.24%)
As of 01:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Day One Biopharmaceuticals (NASDAQ:DAWN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$2.31 M
Get DAWN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Day One Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DAWN Insider Buying and Selling by Quarter

Day One Biopharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2025Adam DubowGeneral CounselSell4,552$6.26$28,495.52  
5/16/2025Charles N York IICFOSell4,282$6.26$26,805.32  
5/16/2025Jeremy BenderCEOSell13,964$6.26$87,414.64  
5/16/2025Lauren MerendinoInsiderSell3,927$6.26$24,583.02  
2/18/2025Adam DubowGeneral CounselSell4,646$11.96$55,566.16  
2/18/2025Charles N York IICFOSell4,370$11.96$52,265.20  
2/18/2025Jeremy BenderCEOSell12,048$11.96$144,094.08  
12/10/2024Samuel C BlackmanInsiderSell30,000$13.31$399,300.00  
11/11/2024Samuel C BlackmanInsiderSell10,000$16.10$161,000.00  
11/7/2024Samuel C BlackmanInsiderSell11,245$16.03$180,257.35  
10/31/2024Samuel C BlackmanInsiderSell500$16.02$8,010.00  
9/10/2024Samuel C BlackmanInsiderSell30,000$14.22$426,600.00  
8/16/2024Adam DubowGeneral CounselSell3,202$14.00$44,828.00  
8/16/2024Charles N York IICFOSell2,633$14.00$36,862.00  
8/16/2024Jeremy BenderCEOSell10,681$14.00$149,534.00  
8/16/2024Samuel C BlackmanInsiderSell2,232$14.00$31,248.00  
7/16/2024Samuel C BlackmanInsiderSell20,000$16.01$320,200.00  
6/21/2024Saira RamasastryDirectorSell10,000$13.19$131,900.00  
(Data available from 1/1/2013 forward)

DAWN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Day One Biopharmaceuticals includes Adam Dubow, Ai Day1 Llc, Charles N York II, Jeremy Bender, Julie Papanek Grant, Lauren Merendino, Michael Gladstone, Papanek Julie Grant, Saira Ramasastry, Samuel C Blackman, and Xi L.P. Canaan. Learn more on insiders at DAWN.

6.20% of Day One Biopharmaceuticals stock is owned by insiders. Learn more on DAWN's insider holdings.

The following insider purchased DAWN shares in the last 24 months: Ai Day1 Llc ($13,867,054.00).

Insiders have purchased a total of 1,153,630 DAWN shares in the last 24 months for a total of $13,867,054.00 bought.

The following insiders have sold DAWN shares in the last 24 months: Adam Dubow ($292,747.39), Charles N York II ($1,301,303.75), Jeremy Bender ($2,117,525.48), Lauren Merendino ($24,583.02), Saira Ramasastry ($131,900.00), and Samuel C Blackman ($2,440,913.90).

Insiders have sold a total of 415,497 Day One Biopharmaceuticals shares in the last 24 months for a total of $6,308,973.54 sold.

Day One Biopharmaceuticals Key Executives



This page (NASDAQ:DAWN) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners